ELDN
Eledon Pharmaceuticals Inc
2.70$
-1.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | – | |
| – | – | – | +187,831.0% | -67.9% | -37.1% | -50.0% | +1,554.5% | +0.5% | +6.6% | +91.3% | +0.3% | -4.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -410.8% | – | – | – | |
| – | +65.5% | +19.5% | +123.9% | -23.3% | -91.9% | +237.1% | +19.2% | -24.6% | +287.1% | +14.1% | +11.9% | +71.4% | +27.5% | |
| – | +55.7% | +150.4% | +42.1% | +3.8% | -15.3% | -34.7% | -16.4% | +66.0% | +30.6% | -3.3% | -0.1% | +46.7% | -8.8% | |
| – | +63.2% | +49.0% | +92.9% | -15.8% | -65.6% | +7.2% | -0.4% | +31.9% | +99.7% | +139.9% | -51.8% | +65.6% | +18.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | – | – | – | -97.9% | +128.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -121.6% | – | – | – | – | -91.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.